IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $241,000 | -68.7% | 7,335 | -73.9% | 0.00% | -75.0% |
| Q2 2020 | $771,000 | +15.8% | 28,101 | +26.3% | 0.00% | 0.0% |
| Q1 2020 | $666,000 | -3.5% | 22,246 | -10.8% | 0.00% | +33.3% |
| Q4 2019 | $690,000 | +52.0% | 24,941 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $454,000 | -61.7% | 24,941 | -48.4% | 0.00% | -66.7% |
| Q2 2019 | $1,185,000 | +100.8% | 48,330 | -22.1% | 0.01% | +100.0% |
| Q1 2019 | $590,000 | – | 62,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,674,299 | $65,948,000 | 5.28% |
| Ghost Tree Capital, LLC | 700,000 | $17,262,000 | 5.05% |
| Perceptive Advisors | 11,489,772 | $283,337,000 | 4.12% |
| Prosight Management, LP | 274,761 | $6,776,000 | 3.73% |
| Fairmount Funds Management LLC | 389,588 | $9,607,000 | 3.49% |
| Avoro Capital Advisors LLC | 8,500,000 | $209,610,000 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 374,495 | $9,235,000 | 3.26% |
| Ally Bridge Group (NY) LLC | 406,986 | $10,036,000 | 2.95% |
| Parametrica Management Ltd | 146,362 | $3,609,000 | 2.70% |
| COMMODORE CAPITAL LP | 362,869 | $8,948,000 | 2.36% |